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East Coast feverEast Coast fever is a lymphoproliferative disease caused by the tick-borne protozoan parasite Theileria
parva. The sporozoite stage of this parasite, harboured and released from the salivary glands of the tick
Rhipicephalus appendiculatus during feeding, invades and establishes infection in bovine lymphocytes.
Blocking this initial stage of invasion presents a promising vaccine strategy for control of East Coast fever
and can in part be achieved by targeting the major sporozoite surface protein p67. To support research on
the biology of T. parva and the identification of additional candidate vaccine antigens, we report on the
sporozoite proteome as defined by LC–MS/MS analysis. In total, 4780 proteins were identified in an
enriched preparation of sporozoites. Of these, 2007 were identified as T. parva proteins, representing
close to 50% of the total predicted parasite proteome. The remaining 2773 proteins were derived from
the tick vector. The identified sporozoite proteins include a set of known T. parva antigens targeted by
antibodies and cytotoxic T cells from cattle that are immune to East Coast fever. We also identified pro-
teins predicted to be orthologs of Plasmodium falciparum sporozoite surface molecules and invasion orga-
nelle proteins, and proteins that may contribute to the phenomenon of bovine lymphocyte
transformation. Overall, these data establish a protein expression profile of T. parva sporozoites as an
important starting point for further study of a parasitic species which has considerable agricultural
impact.
 2018 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
East Coast fever (ECF), a fatal bovine disease, is caused by the
apicomplexan parasite Theileria parva (Norval et al., 1992). The dis-
ease kills approximately one million cattle every year in Africa and
causes significant economic losses to small-hold farmers in east-
ern, central and southern Africa of approximately $300 million
annually (reviewed in Nene et al., 2016). These estimates were
derived several years ago and it is highly likely that the current
losses due to ECF are much larger. Vaccination against ECF by an
infection and treatment method (ITM) is available (Radley et al.,
1975). For control of ECF in southern Africa, except South Africa
where vaccination is not permitted as it is free of ECF, ITM is per-
formed with a single parasite isolate, and in parts of eastern Africa
a composite ITM vaccine, the Muguga cocktail, is used (Morzariaet al., 2000). Although ITM confers solid and long-lived immunity
it has disadvantages in that it is an unstable and potentially lethal
product, and animals vaccinated by the ITM protocol remain life-
long asymptomatic carriers of the parasite that pose risks for
spread of the disease. It also requires a liquid nitrogen cold chain
for storage and oxytetracycline for co-treatment (reviewed in Di
Giulio et al., 2009). The vaccine is expensive and laborious to pro-
duce, and it requires skilled personnel for delivery (reviewed in Di
Giulio et al., 2009). Therefore, development of a subunit vaccine
that is easier to produce and with minimal risks is necessary.
Although classified in the phylum Apicomplexa, aspects of the
biology of Theileria are atypical of such organisms. For example,
Theileria sporozoites are not motile, they have a less defined apical
complex and host cell entry is not orientation-specific (Shaw,
2003). Sporozoites bind and enter bovine lymphocytes by a ‘‘zipper
ing’’ process of the host and the sporozoite cell membranes
(Fawcett et al., 1982). After entry into the host cell, rhoptries/
microspheres are discharged with a rapid escape of the sporozoite
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ate to the schizont stage, which resides in the host cytoplasm sur-
rounded by host cell microtubules that are seemingly nucleated by
parasite molecules (reviewed in Shaw, 2003). Schizont-infected
cells acquire a cancer-like phenotype and are the cause of disease
(Norval et al., 1992). Sporozoites also bind and enter macrophages/
afferent lymph veiled cells by a zippering process, but these cells
are not susceptible to transformation and sporozoites appear to
only differentiate to an early schizont stage (Shaw et al., 1993).
Several host cell signalling pathways that contribute to host cell
transformation have been studied (Dobbelaere and Küenzi, 2004;
Dessauge et al., 2005). In addition, parasite molecules that are
associated with the transformation process have been tentatively
identified by taking advantage of comparative genomics and can-
cer biology (Shiels et al., 2006; Hayashida et al., 2012; Tretina
et al., 2015). A parasite-encoded prolyl isomerase has been recently
identified as playing a key role in this complex host cell transfor-
mation process (Marsolier et al., 2015).
There is good evidence for roles of T. parva sporozoite and sch-
izont antigens as candidate vaccine antigens. Several schizont anti-
gens are targets of cytotoxic T lymphocytes (CTLs) that lyse
schizont-infected cells (Graham et al., 2006, 2007, 2008) and two
sporozoite antigens are targets of neutralising antibodies
(Dobbelaere et al., 1985; Shapiro et al., 1987). One of the latter
antigens, p67, has been shown to consistently protect a proportion
of immunised cattle against challenge with needle-injected sporo-
zoites and from infected ticks in field trials (reviewed in Nene et al.,
2016). The p67-based vaccine might be improved by including
additional antigens that can neutralise sporozoite infectivity.
As a first step towards improving our molecular understanding
of the biology of T. parva we have undertaken a Multidimensional
Protein Identification Technology (MudPIT) LC–MS/MS approach
(reviewed in Schirmer et al., 2003) to characterise the proteome
of T. parva sporozoites purified by ion-exchange chromatography
(Musoke et al., 1992). We have employed bioinformatic tools to
analyse 2007 parasite proteins that we were able to detect and
identified T. parva orthologs of Plasmodium falciparum invasion
organelle proteins, calcium signalling proteins and surface pro-
teins. Some of these may represent novel T. parva vaccine
candidates.2. Materials and methods
2.1. Animals and sporozoite production
The procedure for sporozoites production has been previously
described in detail (Patel et al., 2016). Briefly, cattle aged 7–9
months, previously managed under a strict acaricide regime, were
maintained for at least 2 months and tested for exposure to T.
parva, Theileria mutans, Babesia bigemina and Anaplasma marginale
using ELISA and, in certain instances, with PCR analysis (Morzaria
et al., 1999; Odongo et al., 2010). The naïve cattle were then inoc-
ulated with T. parva stabilates of the Muguga isolate and infection
of the cattle was assessed. A colony of Rhipicephalus appendiculatus
nymphs, previously tested for viruses such as Bovine Viral Diarrhea
virus (BVDV) and Bunya viruses, and demonstrated to be free from
tick-borne haemoparasites (Patel et al., 2016), was then applied to
the infected cattle. The fully-fed nymphs were collected and incu-
bated for 6 weeks at 24 C to induce moulting into adults and
infection rates assessed by microscopy as described before
(Büscher and Tangus, 1986). A total of 300 adult ticks infected with
T. parva Muguga isolate (mean infection rate of 167 acini per tick)
were allowed to feed on rabbits to induce sporozoite maturation.
After 4 days, the tick salivary glands were dissected from the ticks.
All animal procedures described in this article were approved byInternational Livestock Research Institute’s (ILRI, (Kenya)), Insti-
tute Animal Care and Use Committee (IACUC File Number
2014.01).
2.2. Sporozoite purification
Dissected tick salivary glands were collected in a tube with 2 ml
of cold PBS, transferred to a chilled glass hand homogenizer
(‘UNI-FORM’ (England), 4–5 ml of homogenizer) and disrupted by
gentle up, down and circular motion of the pestle until a uniform
cloudy suspension was formed. The suspension was then cen-
trifuged at 1000g at 4 C for 5 min. The resulting supernatant con-
taining sporozoites was applied to an 8 ml diethylaminoethyl
cellulose (DE-52; Sigma–Aldrich (USA) Cat. No. D3764) column
(Musoke et al., 1992). Flow-through fractions of 3.5 ml were col-
lected in siliconised 10 ml conical bottomed glass tubes on ice.
The sporozoite-rich cloudy fractions (numbers 2–5) were pooled
and centrifuged at 12,000g at 4 C for 5 min. The resulting
sporozoite-rich small yellowish pellet was resuspended in SDS–
PAGE sample buffer and heated at 100 C for 5 min prior to fraction-
ation on 10% one-dimensional SDS–PAGE and staining with Coo-
massie Blue.
2.3. In-gel trypsin digestion for LC–MS/MS analysis
The gel lane containing sporozoite material was excised and
divided into four fractions of different size proteins (>100 kDa,
100–55 kDa, 55–35 kDa and <35 kDa). The gel pieces were de-
stained overnight in 50% methanol, 5% acetic acid in water. After
dehydration with acetonitrile, proteins were reduced with 10
mM DTT in 100 mM ammonium bicarbonate, and subsequently
alkylated using 50 mM iodoacetamide in ammonium bicarbonate
for 30 min at room temperature. Following washing of the gel
pieces in 100 mM ammonium bicarbonate, proteolytic digestion
was carried out with 100 ng of trypsin in 50 mM ammonium bicar-
bonate overnight at 37 C. Tryptic peptides were extracted from
each gel with 50% acetonitrile, 5% acetic acid in water, dried and
re-suspended in 20 ll of 2% acetonitrile, 0.1% formic acid in water
for LC–MS/MS analysis.
2.4. LC–MS/MS analysis
Peptides from each gel fraction were separated on an Ultimate
3000 RSLC nano System utilising a PepMap C18 column, 2 mm par-
ticle size, 75 mm  50 cm (Thermo Scientific, USA) and subse-
quently analysed on a QExactive mass spectrometer (Thermo
Scientific, USA). Peptides were introduced into the mass spectrom-
eter using an EASY-SprayTM nano source at a flow rate of 250 nl/min
at approximately 400–600 bars. The 15 most intense precursors
were selected for MS/MS analysis using higher-energy collisional
dissociation (HCD) fragmentation and all fragmented precursor
ions were actively excluded from repeated MS/MS analysis for
27 s.
2.5. Data analysis
2.5.1. Protein identification and relative abundance
RNAseq data of the schizont stage of T. parva has recently been
made available in GenBank (BioSample accession SAMN03981746)
and used to improve the annotation of the genome (da Silva, pers.
comm.). The format for open reading frame (ORF) locus tags in the
re-annotated genome of the Muguga strain has been changed from
TPXX_YYYY (Gardner et al., 2005) to TpMuguga_0Xg0YYYY, where
X stands for the chromosome number and YYYY for the gene num-
ber. This study relied on the re-annotated genome and the new for-
mat for T. parva ORF locus tags has been adopted.
Table 1
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(Bioinformatics solutions) using a database containing all Uniprot
database entries for R. appendiculatus and the re-annotated pro-
teome of T. parva (a total of 16,969 protein entries with 4084 T.
parva and 12,884 R. appendiculatus protein entries, July 2016). A
peptide false discovery rate (FDR) of 1.2% was applied and only
proteins with unique peptide identification were included in the
final sporozoite proteome list.
In order to rank the identified proteins by their abundance in
the sample, an Exponentially Modified Protein Abundance Index
(emPAI) was calculated using Mascot (Matrix Science) (Ishihama
et al., 2005). EmPAI is the exponential form of protein abundance
index (PAI) minus 1 (emPAI = 10PAI  1) and is proportional to pro-
tein content in a protein mixture (Ishihama et al., 2005). PAI is cal-
culated by dividing the number of observed peptides by the
number of observable peptides per protein.
2.5.2. Classification of subcellular localization of the identified T. parva
sporozoite proteins
Proteins were classified according to their putative localization
in the sporozoite using TargetP (Emanuelsson et al., 2000). Trans-
membrane domains (TMDs) were predicted by TMHMM Server v.
2.0 (Krogh et al., 2001), signal peptides (SP) by SignalP 4.1
(Petersen et al., 2011) and glycosylphosphatidylinositol (GPI)-
anchor signal by GPI-SOM (Fankhauser and Mäser, 2005).
2.5.3. Classification of the identified T. parva sporozoite proteins by
orthology
We clustered all sporozoite protein coding sequences of T. parva
with the complete predicted proteome of Plasmodium falciparum
into putative orthologous groups using the OrthoMCL standalone
software Version 2.0.2 (Li et al., 2003). The blast step of OrthoMCL
was performed using an E-value cut-off of 1e10, and minimum
70% sequence identity over 75% sequence coverage. Plasmodium
falciparum 3D7 release of 26-06-2017 sequence data was down-
loaded from PlasmoDB (Aurrecoechea et al., 2010)Abundant Theileria parva sporozoite proteins. Proteins detected from whole cell
lysates of sporozoites are ranked by relative abundance in the sample. Known
antigens are in bold face.
ORF locus taga Annotationb Mass
(Da)
emPAIc
TpMuguga_04g00404 Histone H2B.1 12,040 7228.34
TpMuguga_04g00071 Histone H2B 13,682 900.39
TpMuguga_04g00675 Histone H4 11,362 457.35
TpMuguga_04g00690 Phosphoglycerate mutase 1
family
29,221 105.17
TpMuguga_04g00050 Ribosomal protein S19 17,150 99.38
TpMuguga_03g00655 Hypothetical protein 17,296 96.5
TpMuguga_04g00036 AhpC/TSA family 22,120 84.68
TpMuguga_02g00487 Ribosomal protein S6e 25,553 67.36
TpMuguga_02g00903 Actin 42,270 60.62
TpMuguga_04g00322 Histone H2A 13,498 60.26
TpMuguga_03g00067 Hypothetical protein 11,572 54.06
TpMuguga_01g00726 elF-Tu GTP binding domain 49,779 52.64
TpMuguga_01g00541 Hypothetical protein 24,796 52.36
TpMuguga_04g00383 GAPDH NAD binding domain 36,883 51.37
TpMuguga_01g00701 RAP-1 70,441 47.73
TpMuguga_02g00148 Heat shock 70 kDa protein 71,445 42.22
TpMuguga_04g00179 RanBP1 domain 38,982 41.34
TpMuguga_03g00700 Hypothetical protein 23,995 40.00
TpMuguga_03g00287 Sporozoite P67 surface
antigen
75,453 39.16
TpMuguga_01g00067 Acyl CoA binding protein 10,043 39.11
a Open reading frame (ORF) locus tag refers to a unique T. parva gene identifier.
b Hypothetical protein is of unknown function; AhpC/TSA, alkyl hydroperoxide
reductase subunit C/ thiol specific antioxidant family; elF, elongation factor; RAP-1,
homolog of a Theileria annulata protein annotated as Rhoptry-associated protein 1;
GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; NAD, Nicotinamide adenine
dinucleotide; RanBP1, Ran binding protein 1; CoA, co-enzyme A.
c emPAI, relative protein abundance in sample.3. Results
3.1. Sporozoite proteome determination and relative quantification of
expressed sporozoite proteins
LC–MS/MS was used to identify proteins expressed in a sample
of semi-purified T. parva sporozoites. A complete list of all the pro-
teins identified in this study is provided in Supplementary
Table S1. In total 4780 proteins were identified of which 2007 orig-
inated from T. parva and 2773 from R. appendiculatus. Most pro-
teins (3847) were identified with two or more peptides, while
933 protein identifications were based on a single peptide match,
which includes 296 T. parva proteins (Supplementary Table S2).
Thus, there is higher confidence in the identification of 1711
expressed parasite proteins. Sequence coverage of over 85% was
achieved for three proteins, glyceraldehyde 3-phosphate dehydro-
genase NAD binding domain, histone H2B.1 and ribosomal protein
S21e, all encoded by single copy genes. Protein TpMugu-
ga_03g00168, annotated as a hypothetical protein, was identified
by as many as 94 unique peptides.
The 2007 T. parva sporozoite proteins that were identified rep-
resent approximately 50% of the 4084 proteins predicted to be
encoded by the re-annotated T. parva genome (da Silva, pers.
comm). Of the 2007 proteins, 1287 were further ranked by calcu-
lation of relative abundance in the sample using emPAI values
(Supplementary Table S3), a parameter that is useful for obtaining
an overview of proteome profiles with a wide dynamic range of
concentrations (30 fmol to 1.8 pmol/ll) (Ishihama et al., 2005).The 20 most abundant T. parva sporozoite proteins are shown in
Table 1. Even within this data set, there is a large range in the
abundance of parasite proteins with histones being the most abun-
dant. Other housekeeping proteins, e.g., ribosomal proteins, heat
shock protein 70, phosphoglycerate mutase and glyceraldehyde
3-phosphate dehydrogenase, feature in this list.
3.2. Identification of known T. parva antigens within the sporozoite
proteome
The major circumsporozoite surface protein of T. parva, p67,
which is a target of sporozoite neutralising antibodies
(Dobbelaere et al., 1984), was identified among the 20 most abun-
dant proteins (Table 1). Additional antigens that had been previ-
ously characterised were also identified in this study, e.g., p104
(Ebel et al., 1999), p150 microneme/rhoptry proteins (Skilton
et al., 1998) and p32, a merozoite antigen (Skilton et al., 2000).
We searched the sporozoite proteome data (Supplementary
Table S1) for characterised schizont CD8 T cell antigens (Graham
et al., 2006, 2008) and found evidence for expression of all known
CTL antigens (reviewed in Nene and Morrison, 2016) in the sporo-
zoite stage. In contrast to CD8 T cell antigens, CD4 T cell antigens
still require better characterization. CD4 antigens are presented
by intact schizont-infected cells (Brown et al., 1989) as well as cell
extracts (Ballingall et al., 2000). Soluble cytosolic parasite antigens
stimulatory to CD4 T cell clones with fractions ranging between 10
and 24 kDa (Brown et al., 1995) have been described, but further
analysis and identification of the specific constituent proteins is
required. However, among the most abundant sporozoite proteins
we identified a protein that is homologous to a Theileria annulata
protein annotated as rhoptry associated protein-1 (RAP-1)
(Table 1). RAP-1 of B. bigemina has been shown to be a CD4 T cell
antigen (Brown et al., 1999), suggesting that the T. parva RAP-1 is
a potential CD4 T cell antigen.
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invasion of host cells
Sporozoite secretory organelle proteins are typically located in
the micronemes, rhoptries and dense granules in P. falciparum
(reviewed in Lindner et al., 2013). To determine whether these pro-
teins are present in T. parva sporozoites, we clustered our identi-
fied T. parva sporozoite proteins, using OrthoMCL, into
orthologous groups with all P. falciparum genes. A total of 1105
proteins of the 2007 T. parva proteins were defined as P. falciparum
orthologs (Supplementary Table S4) and we searched this list for
apical organelle proteins. We identified T. parva orthologs of eight
rhoptry proteins, three microneme proteins and a dense granule
protein (Table 2). Featured in the list are orthologs of P. falciparum
apical membrane antigen 1 (AMA-1), a microneme protein essen-
tial during host cell invasion (Treeck et al., 2009), and cell-
traversal protein for ookinetes and sporozoites (CelTOS), a malarial
antigen mediating host cell invasion (Kariu et al., 2006). AMA-1 is a
leading malaria vaccine candidate (Remarque et al., 2008), and
orthologs of it are also found in Neospora caninum and Toxoplasma
gondii (Zhang et al., 2007).
In T. parva, mobilisation of Ca2+ is necessary for successful
sporozoite invasion of bovine lymphocytes and reagents that pre-
vent Ca2+ mobilisation significantly curb zippering and internalisa-
tion stages of the entry process (Shaw, 1995). Table 3 shows 13
proteins identified in T. parva clustered with the Plasmodium pro-
teins that play a role in calcium signalling, including calmodulin,
an intracellular target for Ca2+ activation that acts on proteins such
as guanylyl cyclases, protein kinases and phosphatases to aid in
signal transduction.
3.4. Putative T. parva surface proteins within the sporozoite proteome
We used two methods to search for novel putative surface pro-
teins. The first method was to use bioinformatics tools to predictTable 2
Invasion organelle proteins. Proteins detected from whole cell lysates of Theileria parva saliv
proteins.
Orthologous group Organism ORF locus tag a Gene nameb
Rhoptry proteins
OG5_142870 P. falciparum PF3D7_1452000 PfRON2
T. parva TpMuguga_01g00014 –
OG5_153587 P. falciparum PF3D7_0817700 RON5
T. parva TpMuguga_01g01161 –
OG5_153563 P. falciparum PF3D7_1347500 ALBA4
T. parva TpMuguga_02g00645 –
OG5_128020 P. falciparum PF3D7_0932300 PfM18AAP
T. parva TpMuguga_01g01150 –
OG5_145111 P. falciparum PF3D7_0906000 RNaseII
T. parva TpMuguga_01g00396 –
OG5_141731 P. falciparum PF3D7_1361800 GAC
T. parva TpMuguga_01g00092 –
OG5_129273 P. falciparum PF3D7_0814200 ALBA1
T. parva TpMuguga_03g00655
OG5_154281 P. falciparum PF3D7_1006200 ALBA3
T. parva TpMuguga_03g00067
Microneme proteins
OG5_147452 P. falciparum PF3D7_1133400 AMA1
T. parva TpMuguga_01g00650 –
falciparum
OG5_171217 P. falciparum PF3D7_1216600 CelTOS
T. parva TpMuguga_01g00232 –
OG5_135185 P. falciparum PF3D7_0212900 –
T. parva TpMuguga_02g00627 –
Dense granules
OG5_126706 P. falciparum PF3D7_0818200 –
T. parva TpMuguga_02g00607
a Open reading frame (ORF) locus tag refers to a unique T. parva or P. falciparum gene
b Gene name is as defined in P. falciparum.the presence of GPI anchors and SP in proteins expressed by sporo-
zoites. Only 12 proteins of the 2007 sporozoite proteins were found
in this category (Table 4). The list includes TpMuguga_01g00939
(gp34), a protein that undergoes GPI modification when expressed
in mammalian cells and a schizont surface protein (Xue et al.,
2010). Since there is no direct evidence for addition of GPI anchors
to parasite expressed proteins, we searched for enzymes of the GPI
biosynthesis pathway encoded by the T. parva genome. Eight genes
are essential for GPI synthesis in P. falciparum (Delorenzi et al.,
2002). We found homologs of all eight genes in T. parva (TpMugu-
ga_04g00759, TpMuguga_04g00881, TpMuguga_04g00525, TpMu-
guga_01g00169, TpMuguga_02g00201, TpMuguga_03g00397,
TpMuguga_03g00846 and TpMuguga_02g00741) and identified
that the latter four are expressed in the sporozoite proteome. This
suggests the existence of GPI anchored proteins in T. parva,
although this remains to be formally proven.
Secondly, we compiled from the literature a list of surface-
exposed P. falciparum proteins and determined if orthologs exist
within the T. parva sporozoite proteome. We identified orthologs
of AMA-1 (TpMuguga_01g00650) and a hexose transporter (TpMu-
guga_01g01069) which were both identified by specific biotinyla-
tion of P. falciparum and Plasmodium yoelii surface proteins
(Lindner et al., 2013).
3.5. Theileria parva proteins as candidate manipulators of host cell
signalling leading to transformation
Lymphocyte transformation characterised by cancer-like cell
phenotypes is solely dependent on viable schizonts and requires
the schizont proteins to interact with and manipulate pathways
regulating lymphocyte apoptosis, proliferation and gene expres-
sion (Dobbelaere and Heussler, 1999; Tretina et al., 2015). We
identified 17 proteins predicted to be manipulators of host cells
(Shiels et al., 2006) in the sporozoite stage, suggesting that these
proteins may be required immediately upon host cell entry.ary gland sporozoites are aligned by orthology with Plasmodium falciparum sporozoite
Annotation (reference)
Rhoptry neck protein 2 (Cao et al., 2009)
Hypothetical protein
Conserved Plasmodium protein, unknown function (Curtidor et al., 2011)
Hypothetical protein
Conserved Plasmodium protein, unknown function (Sam-Yellowe et al., 2004)
Hypothetical protein
M18 aspartyl aminopeptidase (Lauterbach and Coetzer, 2008)
aspartyl aminopeptidase
RNB-like protein, putative (Sam-Yellowe et al., 2004)
Hypothetical protein
Conserved Plasmodium protein, unknown function (Sam-Yellowe et al., 2004)
Hypothetical protein
DNA/RNA-binding protein Alba 1(Lindner et al., 2013)
Hypothetical protein
DNA/RNA-binding protein Alba 3 (Lindner et al., 2013)
Hypothetical protein
Apical membrane antigen 1, AMA1 (Cowman and Crabb, 2006)
Apical membrane antigen 1
Cell-traversal protein for ookinetes and sporozoites, putative (Kariu et al., 2006)
Hypothetical protein
Leu/Phe-tRNA protein transferase, putative (Lindner et al., 2013)
Leucyl/phenylalanyl-tRNA protein transferase




Proteins involved with calcium signalling. Proteins detected from whole cell lysates of Theileria parva salivary gland sporozoites are aligned by orthology with Plasmodium
falciparum sporozoite proteins.
Orthologous Group Organism ORF locus taga Gene nameb Annotation (reference)
OG5_126800 P. falciparum PF3D7_1434200 CAM Calmodulin
T. parva TpMuguga_02g00717 – Calmodulin
OG5_129380 P. falciparum PF3D7_1027700 PfCEN1 Centrin-1 (Khan et al., 2005)
T. parva TpMuguga_01g00227 – Centrin
OG5_152981 P. falciparum PF3D7_1140000 CA Carbonic anhydrase (Lindner et al., 2013)
T. parva TpMuguga_02g00412 – Hypothetical protein
OG5_126600 P. falciparum PF3D7_0717500 PfCDPK4 Calcium-dependent protein kinase 4 (Holder et al., 2012)
T. parva TpMuguga_01g01073 – Calmodulin-domain protein kinase
P. falciparum PF3D7_1337800 CDPK5 Calcium-dependent protein kinase, (Dvorin et al., 2010)
T. parva TpMuguga_02g00399 – Calcium-dependent protein kinase
OG5_131887 P. falciparum PF3D7_1123100 CDPK7 Calcium-dependent protein kinase 7 (Lindner et al., 2013)
T. parva TpMuguga_04g00518 – Protein tyrosine kinase
OG5_127599 P. falciparum PF3D7_1436600 PKG cGMP-dependent protein kinase (Lindner et al., 2013)
T. parva TpMuguga_03g00511 Protein tyrosine kinase
OG5_133188 P. falciparum PF3D7_1138400 GCalpha Guanylyl cyclase (Pradel, 2007)
T. parva TpMuguga_02g00848 – Guanylyl cyclase
OG5_141757 P. falciparum PF3D7_1246400 MTIP Myosin A tail domain interacting protein (Jones et al., 2006)
T. parva TpMuguga_01g00513 – Myosin light chain
OG5_126577 P. falciparum PF3D7_1329100 MyoC Myosin C(Tyagi et al., 2009)
T. parva TpMuguga_01g00774 – Myosin C
OG5_126674 P. falciparum PF3D7_1211900 ATPase4 Non-SERCA-type Ca2+ –transporting P-ATPase (Budu and Garcia, 2012)
P. falciparum PF3D7_0106300 ATP6 Calcium-transporting ATPase, putative (Budu and Garcia, 2012)
T. parva TpMuguga_01g00720 – P-type ATPase
T. parva TpMuguga_02g00524 – Calcium-transporting ATPase
OG5_127599 P. falciparum PF3D7_0934800 PKAc cAMP-dependent protein kinase catalytic subunit (Lindner et al., 2013)
T. parva TpMuguga_02g00378 – cAMP-dependent protein kinase
a Open reading frame (ORF) locus tag refers to a unique T. parva or P. falciparum gene identifier.
b Gene name is as defined in P. falciparum.
Table 4
Potential sporozoite surface proteins. Proteins detected from whole cell lysates of Theileria parva salivary gland sporozoites predicted to contain a glycosylphosphatidylinositol
anchor and either transmembrane domain or signal peptide.
ORF locus taga Annotationb Unique peptidesc emPAId TMDe GPI-anchorf SPg
TpMuguga_01g00438 Hypothetical protein 34 1.01 0 1 1
TpMuguga_01g00939 Hypothetical protein (gp34) 12 3.65 1 1 1
TpMuguga_01g00939 Hypothetical protein 12 3.65 1 1 1
TpMuguga_01g00972 Hypothetical protein 4 0.45 1 1 1
TpMuguga_01g01056 Merozoite antigen (p32) 12 6.78 0 1 1
TpMuguga_02g00412 Hypothetical protein 5 0.3 0 1 1
TpMuguga_02g00538 Hypothetical protein 31 1.34 1 1 1
TpMuguga_02g00553 Hypothetical protein 6 2.95 1 1 1
TpMuguga_02g00950 Hypothetical protein 2 <0.05 1 1 1
TpMuguga_03g00287 Sporozoite p67 surface antigen 53 39.16 1 1 1
TpMuguga_04g00437 104 kDa microneme/rhoptry antigen (p104) 60 12.35 1 1 1
TpMuguga_04g00615 Probable N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase 2 <0.05 0 1 1
a Open reading frame (ORF) locus tag refers to a unique T. parva gene identifier.
b Hypothetical protein is of unknown function(s).
c Unique peptides refers to the total number of peptides identified matching the protein sequence that do not match any other protein in the database searched.
d emPAI, relative protein abundance in sample.
e Predicted using the TMHMM Server v. 2.0 (http://www.cbs.dtu.dk/services/TMHMM/).
f Predicted using the GPI-SOM (http://gpi.unibe.ch/).
g Predicted using the SignalP 4.1 server (http://www.cbs.dtu.dk/services/SignalP/).
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RNAseq data from schizont-infected cells (see Section 2.5.1),
although at different levels (Supplementary Table S5). Among the
identified proteins are members of two multigene families, the
Sub-telomere-encoded Variable Secreted Protein (SVSP) gene fam-
ily and the T. annulata schizont AT-hook (TashAT) gene family, or T.
parva host nuclear (TpHN) gene family. TashAT proteins display a
high degree of sequence conservation in their DNA-binding
domains (AT-hook) in T. annulata but not in T. parva and contain
an N-terminal signal sequence for transport across the parasite
plasma membrane (reviewed in Tretina et al., 2015). TashAT family
proteins are implicated in regulation of host gene expression and
as accessory factors for parasite transcription (Shiels et al., 2006).
Other families featured are DEAD-box RNA helicases with mem-bers implicated in alteration of RNA secondary structures and pro-
motion of proto-oncogene c-myc expression (e.g., DDX6)
(Abdelhaleem, 2004), thioredoxin/glutaredoxin family that are
redox regulators and influence important signalling pathways such
as nuclear factor kappa light chain enhancer of activated B cells
(NF-kB) and activator protein-1 (AP1) pathways that are both acti-
vated in Theileria-transformed cells (Shiels et al., 2006). In addition,
we identified T. parva Schizont-derived Cytoskeleton-binding Pro-
tein (TpSCOP), a protein that activates host NF-jB and mitogen-
activated protein kinase (MAPK) pathways, leading to resistance
to programmed host cell death (Hayashida et al., 2010) and a
peptidyl-prolyl isomerase, which has been demonstrated to inter-
act with and lead to degradation of host ubiquitin ligase FBW7,
thereby stabilising host c-JUN and promoting transformation of
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RNAseq data identified a high level of anti-sense transcription of
the TpSCOP gene (Supplementary Table S5), suggesting that
expression of this gene in the schizont stage may be under differ-
ential control. Resolution of the significance of this observation will
require analysis of cell-cycle synchronised samples.
3.6. Sporozoite proteins involved in glycolysis and tricarboxylic acid
(TCA) cycles
Proteins of the glycolytic pathway are conserved in most
eukaryotic organisms and 10 genes encoding glycolytic enzymes
have been found in Theileria genomes (Gardner et al., 2005; Pain
et al., 2005). We identified expression of all the 10 enzymes of
the glycolytic pathway in this study (Fig. 1) including lactate dehy-
drogenase (LDH), an enzyme that converts pyruvate, the last pro-
duct of glycolysis, to lactate during low or no oxygen conditions.
We also identified all the TCA cycle enzymes by MS (Fig. 1) with
the exception that malate dehydrogenase is functionally replaced
by malate-quinone oxidoreductase (Gardner et al., 2005), and
was identified in the proteome data. Glutamate dehydrogenase
was also identified in the proteome and glutamate has been sug-
gested to be a supplementary intermediate for the TCA cycleFig. 1. Most of Theileria parva proteins involved in glycolysis and tricarboxylic acid cyc
tricarboxylic acid cycle is shown on the right. Colour code for proteins: green, enzymes
identified by MS; red, enzymes not encoded by the T. parva genome and not identified in
brackets (see below): HK, hexokinase (TpMuguga_01g00043); GPi, glucose 6-pho
ga_02g00577); FBP, fructose bisphosphatase; FBA, fructose bisphosphate aldolase (Tp
3PDH, glycerol-3-phosphate dehydrogenase; Gly-K, glycerol kinase; GAPDH, glyceralde
kinase (TpMuguga_01g00965); PGM-1, phosphoglycerate mutase (TpMuguga_04g00690
TpMuguga_04g00607); LDH, lactate dehydrogenase (TpMuguga_01g01182); PC, pyruva
dehydrogenase (TpMuguga_04g00620); OGDH, oxoglutarate dehydrogenase (TpMuguga_
dehydrogenase (TpMuguga_01g00210); FH, fumarate hydratase-1 (TpMuguga_03g0
(TpMuguga_03g00758); CS, citrate synthase (TpMuguga_02g00666); PEPC, phosphoe
ga_01g00495). (For interpretation of the references to colour in this figure legend, the r(Gardner et al., 2005). The only functional link we have found
between glycolysis and the TCA cycle is the presence of phospho-
enolpyruvate carboxykinase. Neither glycerol kinase nor glycerol
3-phosphate dehydrogenase were identified, although T. parva
encodes genes for both enzymes. These enzymes were identified
with low levels in the schizont stage of T. annulata (Witschi
et al., 2013).3.7. Tick proteins
Searching the Uniprot database entries for R. appendiculatus
with the LC–MS/MS data led to identification of 2773 tick proteins
in addition to the T. parva proteins. The complete list of all the
identified tick proteins is presented in Supplementary Table S1,
but a detailed analysis of vector proteins will be reported
elsewhere.4. Discussion
In this study, we employed a DE-52 ion-exchange column
purification method to semi-purify T. parva sporozoites from
infected tick salivary glands. Although tick proteins constitutedles were identified in this study. The glycolysis pathway is shown on the left and
that were identified by MS; blue, enzymes encoded in the T. parva genome but not
this study. Enzymes identified by MS have open reading frame locus tags included in
sphate-isomerase (TpMuguga_03g00346); PFK, phosphofructokinase (TpMugu-
Muguga_01g00101); TPI, triosephosphate isomerase (TpMuguga_04g00464); Gly-
hyde phosphate dehydrogenase (TpMuguga_02g00858); PGK-1, phosphoglycerate
); ENO, enolase (TpMuguga_04g00700); PK, pyruvate kinase (TpMuguga_02g00134,
te carboxylase; ACH, aconitate hydratase-1 (TpMuguga_01g01050); IDH, isocitrate
01g00262); SCL, succinyl coenzyme A ligase (TpMuguga_04g00660); SDH, succinate
0078); MDH, malate dehydrogenase; MQOR, Malate: quinone oxidoreductase
nolpyruvate carboxylase; PEPCK, phosphoenolpyruvate carboxykinase (TpMugu-
eader is referred to the web version of this article.)
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identified by LC–MS/MS and the Peaks and Mascot software pack-
ages, we were able to identify 2007 T. parva proteins expressed in
the sporozoite life-cycle stage. This represents 50% of the total
predicted re-annotated T. parva proteome of 4084 proteins (see
Section 2.5.1). Approximately 40% of these proteins are annotated
as hypothetical proteins. Hence, our data provides evidence that
real genes encode these proteins, although their functions remain
unknown.
Studies on the proteome of P. falciparum sporozoite stages have
reported identification of 13% (Lasonder et al., 2008), 19%
(Florens et al., 2002) and 36% (Lindner et al., 2013) of the 5524
annotated P. falciparum genes using materials purified by DEAE-
cellulose chromatography only (Florens et al., 2002; Lasonder
et al., 2008), and on 17% w/v Accudenz cushion followed by
DEAE-cellulose chromatography (Lindner et al., 2013). The range
of vector contamination is an important component of such studies
and varied depending on the method of parasite purification.
Lasonder et al. (2008) reported 65–89% mosquito protein contam-
ination in the samples analysed, while Lindner et al. (2013)
reported 60.1% mosquito proteins in the sample, but had to per-
form double purification, initially on a 17% w/v Accudenz cushion
then followed by DEAE-cellulose chromatography, to reduce mos-
quito protein contamination to 29% (Lasonder et al., 2008; Lindner
et al., 2013). The presence of mosquito material in the sample was
not discussed by Florens et al. (2002). We managed to achieve low
levels of vector protein contamination with a single DE-52 column
purification step.
Positive identification of proteins by MS confers confidence in
their presence, especially when the proteins are identified by more
than one unique peptide hit. Of the 2007 parasite proteins, 1708
were identified by more than one hit, providing a high degree of
confidence in 85% of the data. For the purposes of our current anal-
yses we have, however, reported on the entire data set of 2007 pro-
teins. Failure to identify T. parva proteins does not directly imply
their absence in the sample. Peptides from proteins with low abun-
dance may fall below the detection limit or are simply not
sequenced by the mass spectrometer due to limited dynamic range
and/or speed of instrument acquisition. Furthermore, unknown,
complex, or amino acid modifications leading to alteration of the
peptide mass can only be detected in some cases by the Peaks soft-
ware. Finally, trypsin digestion of proteins with low or irregular
arginine/lysine content can lead to very short and very long tryptic
peptides that fall out of the acquired mass range, and may there-
fore not be detected.
Identification of T. parva sporozoite proteins through MS has
allowed us to assess the proteomic component of the
mammalian-infective stage of the parasite. We have also calcu-
lated the emPAI using Mascot to estimate the relative abundance
ranking of proteins in the sample, which revealed a very high range
of abundance with histones ranked with an emPAI of 60–7200 for
the different histone subunits to an emPAI index of 39 for the
major circumsporozoite p67 protein. Subunits of two enzymes
within the glycolytic pathway, phosphoglycerate mutase and glyc-
eraldehyde 3-phosphate dehydrogenase, are among the 20 most
abundant sporozoite proteins detected (Table 1). A high abundance
of histones is not unusual. Lindner et al. (2013) reported histones
as the third most abundant protein in Plasmodium sporozoite pro-
teome after the circumsporozoite protein and mitochondrial ATP
synthase, subunit beta (Lindner et al., 2013).
A number of known antigens were identified within the sporo-
zoite proteome including p67, a leading vaccine antigen, and pre-
viously described components of secretory organelles (e.g., p104
and p150) (Table 4). RAP-1, a rhoptry antigen protective against
P. falciparum infection in Saimiri monkeys (Ridley et al., 1990),
was also identified (Table 1). Unexpectedly, the polymorphicimmuno-dominant molecule (PIM), a well-known antigen (Toye
et al., 1991), was not identified in this study even though p150,
an antigen that is immunologically cross-reactive with PIM
(Skilton et al., 1998), was identified. The PIM protein sequence con-
tains a large repetitive domain rich in glutamine and proline amino
acid residues that is devoid of lysine and arginine residues (Toye
et al., 1991). An in silico digestion of PIM with trypsin leads to pre-
diction of few detectable tryptic peptides (data not shown). This
may explain why we did not detect it. All schizont proteins that
have been identified as CTL antigens are also expressed in sporo-
zoites (emPAI range of 0.76–31.69). Some of these antigens are
encoded by housekeeping proteins (e.g., hsp90) and translation
elongation initiation factor 1A, so expression by sporozoites of
some CTL antigens is not unexpected. The finding that all the
known CTL antigens are expressed by sporozoites raises the ques-
tion of whether infection of dendritic cells by sporozoites results in
direct presentation of antigen for priming CTL responses in vivo,
provided the antigen load is sufficient.
A study on the proteome of T. annulata schizont stage, in which
798 proteins were identified, failed to identify any member of SVSP
and TashAT families (Witschi et al., 2013). In contrast, we identi-
fied members of both families in the sporozoite stage (Supplemen-
tary Table S5). There is increasing evidence pointing to a role of
these proteins in host-parasite interaction, for instance SVSP
epitope-tagged TpMuguga_03g00882 protein expressed in mam-
malian cells was found to translocate into the host nucleus, point-
ing to potential role in transforming host cells (Schmuckli-Maurer
et al., 2009). In addition, we identified other predicted host manip-
ulation proteins such as DEAD-box RNA helicases, peptidases and
two proteins, namely a peptidyl prolyl-isomerase and TpSCOP,
demonstrated to play roles in host manipulation by stabilising c-
JUN and activation of NF-kB, respectively (Shiels et al., 2006;
Hayashida et al., 2010; Marsolier et al., 2015). Host cell manipula-
tion is known to occur at the schizont stage and the finding of these
proteins in the sporozoite stage suggests early expression of these
proteins may be required, or multi-functionality of the proteins.
Sporozoite invasion of lymphocytes begins with binding events
that trigger the mobilisation of Ca2+ within the sporozoites
(Dobbelaere and Heussler, 1999). The free intracellular Ca2+ can
be utilised by calmodulin to remodel itself structurally so as to
act on downstream effectors such as calcium-dependent protein
kinases (CDPKs), which have been shown to be useful for parasite
infectivity. We detected both calmodulin and CDPKs in this study
(Table 3). We also detected other calcium signalling proteins
including guanylyl cyclases, cGMP-dependent protein kinases
and cAMP-dependent protein kinases, all of which are important
for downstream calcium signalling and have been shown to be
essential for sporozoite invasion (reviewed in Dobbelaere and
Heussler, 1999).
In motile apicomplexans such as Plasmodium, free calcium
induces microneme secretion by sporozoites to aid in gliding
motility and host invasion (Lindner et al., 2013). Although T. parva
sporozoites are immotile (Shaw, 2003), we identified orthologs of
Plasmodium microneme components, including AMA-1, CelTOS
and Leu/Phe-tRNA protein transferase (Cowman and Crabb, 2006;
Kariu et al., 2006; Lindner et al., 2013). These proteins may be
involved solely in invasion processes, together with the detected
rhoptry proteins (PfRON2, Conserved Plasmodium protein,
PfM18AAP and RNB-like protein) and dense granules protein (14-
3-3 protein) (Sam-Yellowe et al., 2004; Lauterbach and Coetzer,
2008; Cao et al., 2009; Curtidor et al., 2011; Lindner et al., 2013).
Since most of these proteins are still classified as hypothetical in
T. parva, they present an opportunity for further analysis in studies
aiming to block parasite invasion of host cells.
In conclusion, these data establish the expression profile of T.
parva sporozoite proteins, the only such profile available to date.
272 J. Nyagwange et al. / International Journal for Parasitology 48 (2018) 265–273One or more of the newly identified proteins, in particular putative
surface proteins, may prove to be effective vaccine candidates and
might be combined with the major surface protein p67 to induce
broader anti-sporozoite immunity, and protection against ECF.
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